Vigilant Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$170K Hold
339
0.01% 162
2023
Q1
$170K Sell
339
-75
-18% -$35.9K 0.01% 156
2022
Q4
$169K Hold
414
0.01% 158
2022
Q3
$135K Buy
414
+4
+1% +$1.47K 0.01% 186
2022
Q2
$144K Hold
410
0.01% 181
2022
Q1
$224K Sell
410
-234
-36% -$123K 0.02% 157
2021
Q4
$424K Sell
644
-6
-0.9% -$3.77K 0.03% 129
2021
Q3
$404K Sell
650
-34
-5% -$22.8K 0.03% 101
2021
Q2
$432K Sell
684
-10
-1% -$5.52K 0.03% 97
2021
Q1
$340K Sell
694
-70
-9% -$35.1K 0.03% 103
2020
Q4
$382K Sell
764
-460
-38% -$206K 0.04% 86
2020
Q3
$481K Buy
1,224
+200
+20% +$73.9K 0.05% 76
2020
Q2
$338K Sell
1,024
-100
-9% -$29K 0.04% 91
2020
Q1
$272K Sell
1,124
-182
-14% -$47.5K 0.04% 88
2019
Q4
$341K Buy
1,306
+246
+23% +$64.8K 0.04% 99
2019
Q3
$288K Hold
1,060
0.04% 98
2019
Q2
$292K Hold
1,060
0.04% 95
2019
Q1
$237K Buy
1,060
+460
+77% +$95K 0.03% 111
2018
Q4
$112K Hold
600
0.02% 171
2018
Q3
$150K Hold
600
0.02% 160
2018
Q2
$131K Hold
600
0.02% 161
2018
Q1
$115K Buy
600
+400
+200% +$73.8K 0.02% 157
2017
Q4
$31K Buy
+200
New +$31.5K ﹤0.01% 267
2015
Q1
Sell
-400
Closed -$30K 279
2014
Q4
$30K Hold
400
0.01% 215
2014
Q3
$24K Hold
400
0.01% 213
2014
Q2
$27K Hold
400
0.01% 190
2014
Q1
$24K Sell
400
-400
-50% -$23.8K 0.01% 212
2013
Q4
$43K Hold
800
0.01% 157
2013
Q3
$40K Hold
800
0.01% 141
2013
Q2
$36K Buy
+800
New +$35K 0.01% 149

Other funds holding IDXX

Vigilant Capital Management's IDXX Position: Q2 2023 in Review

Vigilant Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2023 at 339 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #162.

Vigilant Capital Management first reported a position in IDXX in Q2 2013 and has held it in 30 quarters since. The position peaked at $481K in Q3 2020. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Vigilant Capital Management held 339 shares of Idexx Laboratories worth $170K as of Q2 2023.
  • Vigilant Capital Management left its Idexx Laboratories share count unchanged in Q2 2023.
  • Idexx Laboratories made up 0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #162 holding.
  • Vigilant Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 30 quarters since.
  • Vigilant Capital Management's Idexx Laboratories position peaked at $481K in Q3 2020.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.